Omnio, a Umeå-based #BioTech startup, has raised an #oversubscribed €2.9 million round from existing investors and shareholders to advance its plasminogen-based...

Omnio, a Umeå-based #BioTech startup, has raised an #oversubscribed €2.9 million round from existing investors and shareholders to advance its plasminogen-based #therapy for chronic wounds toward clinical studies. 🇸🇪 🧬 🦵

https://t.co/mH0nPBYrYb